Metropolis Healthcare Share Price
Sector: Healthcare Facilities
1705.90 -0.15 (-0.01%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1697.15
Today’s High
1728.40
52 Week Low
1383.70
52 Week High
2306.85
1700.00 -4.80 (-0.28%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1696.10
Today’s High
1731.30
52 Week Low
1315.00
52 Week High
2318.30
Key Metrics
- Market Cap (In Cr) 8766.06
- Beta 0.72
- Div. Yield (%) 0
- P/B 7.97
- TTM P/E 69.89
- Peg Ratio -5.04
- Sector P/E 22.89
- Open Price 1722.05
- Prev Close 1706.05
Metropolis Healthcare Analysis
Price Analysis
-
1 Week-2.73%
-
3 Months-0.24%
-
6 Month-19.55%
-
YTD-17.91%
-
1 Year-4.97%
Risk Meter
- 31% Low risk
- 31% Moderate risk
- 31% Balanced Risk
- 31% High risk
- 31% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 5
- 5
- 4
- 3
- Buy
- 5
- 5
- 5
- 6
- Hold
- 1
- 1
- 1
- 1
- Sell
- 3
- 3
- 3
- 4
- Strong Sell
- 1
- 1
- 1
- 2
- Total
- 15
- 15
- 14
- 16
Metropolis Healthcare News
Metropolis Healthcare amps up North India play with Agra lab chain acquisition
3 min read . 03 Mar 2025Metropolis Health to push regional growth with micro mkt focus: CEO Chemmenkotil
3 min read . 05 Feb 2025Metropolis Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1207.71
- Selling/ General/ Admin Expenses Total
- 637.15
- Depreciation/ Amortization
- 94.47
- Other Operating Expenses Total
- 5.74
- Total Operating Expense
- 1009.7
- Operating Income
- 198.01
- Net Income Before Taxes
- 174.69
- Net Income
- 127.82
- Diluted Normalized EPS
- 24.87
- Period
- 2024
- Total Assets
- 1555.06
- Total Liabilities
- 458.91
- Total Equity
- 1096.16
- Tangible Book Valueper Share Common Eq
- 49.8
- Period
- 2024
- Cashfrom Operating Activities
- 263.56
- Cashfrom Investing Activities
- -89.41
- Cashfrom Financing Activities
- -181.2
- Net Changein Cash
- -6.22
- Period
- 2023
- Total Revenue
- 1148.21
- Selling/ General/ Admin Expenses Total
- 575.25
- Depreciation/ Amortization
- 89.22
- Other Operating Expenses Total
- 5.77
- Total Operating Expense
- 944.64
- Operating Income
- 203.57
- Net Income Before Taxes
- 187.5
- Net Income
- 142.88
- Diluted Normalized EPS
- 27.83
- Period
- 2023
- Total Assets
- 1501.61
- Total Liabilities
- 513.38
- Total Equity
- 988.23
- Tangible Book Valueper Share Common Eq
- 30.99
- Period
- 2023
- Cashfrom Operating Activities
- 247.09
- Cashfrom Investing Activities
- 46.79
- Cashfrom Financing Activities
- -292.33
- Net Changein Cash
- 2.85
- Period
- 2022
- Total Revenue
- 1228.34
- Selling/ General/ Admin Expenses Total
- 585.21
- Depreciation/ Amortization
- 63.22
- Other Operating Expenses Total
- 1.73
- Total Operating Expense
- 930.99
- Operating Income
- 297.35
- Net Income Before Taxes
- 293.35
- Net Income
- 214.18
- Diluted Normalized EPS
- 39.43
- Period
- 2022
- Total Assets
- 1530.29
- Total Liabilities
- 644.1
- Total Equity
- 886.2
- Tangible Book Valueper Share Common Eq
- 13.72
- Period
- 2022
- Cashfrom Operating Activities
- 253.27
- Cashfrom Investing Activities
- -737.57
- Cashfrom Financing Activities
- 162.52
- Net Changein Cash
- -323.14
- Period
- 2021
- Total Revenue
- 997.99
- Selling/ General/ Admin Expenses Total
- 436.9
- Depreciation/ Amortization
- 45.94
- Other Operating Expenses Total
- 2.62
- Total Operating Expense
- 755.08
- Operating Income
- 242.91
- Net Income Before Taxes
- 244.32
- Net Income
- 183.1
- Diluted Normalized EPS
- 35.79
- Period
- 2021
- Total Assets
- 1004.42
- Total Liabilities
- 297.81
- Total Equity
- 706.6
- Tangible Book Valueper Share Common Eq
- 113.83
- Period
- 2021
- Cashfrom Operating Activities
- 249.03
- Cashfrom Investing Activities
- 61.7
- Cashfrom Financing Activities
- -32.69
- Net Changein Cash
- 279.42
- Period
- 2020
- Total Revenue
- 856.41
- Selling/ General/ Admin Expenses Total
- 415.95
- Depreciation/ Amortization
- 39.27
- Other Operating Expenses Total
- 4.68
- Total Operating Expense
- 686.77
- Operating Income
- 169.63
- Net Income Before Taxes
- 168.73
- Net Income
- 127.33
- Diluted Normalized EPS
- 25.84
- Period
- 2020
- Total Assets
- 752.23
- Total Liabilities
- 228.74
- Total Equity
- 523.5
- Tangible Book Valueper Share Common Eq
- 79.99
- Period
- 2020
- Cashfrom Operating Activities
- 215
- Cashfrom Investing Activities
- -104.83
- Cashfrom Financing Activities
- -55.32
- Net Changein Cash
- 55.8
- Period
- 2019
- Total Revenue
- 761.18
- Selling/ General/ Admin Expenses Total
- 365.89
- Depreciation/ Amortization
- 20.07
- Other Operating Expenses Total
- 4.79
- Total Operating Expense
- 580.84
- Operating Income
- 180.34
- Net Income Before Taxes
- 186.55
- Net Income
- 120.15
- Diluted Normalized EPS
- 24.01
- Period
- 2019
- Total Assets
- 552.64
- Total Liabilities
- 134.1
- Total Equity
- 418.54
- Tangible Book Valueper Share Common Eq
- 63.1
- Period
- 2019
- Cashfrom Operating Activities
- 90.15
- Cashfrom Investing Activities
- 35.34
- Cashfrom Financing Activities
- -118.15
- Net Changein Cash
- 7.9
- Period
- 2018
- Total Revenue
- 647.16
- Selling/ General/ Admin Expenses Total
- 300.46
- Depreciation/ Amortization
- 19.02
- Other Operating Expenses Total
- 3.78
- Total Operating Expense
- 487.57
- Operating Income
- 159.59
- Net Income Before Taxes
- 163.68
- Net Income
- 104.24
- Diluted Normalized EPS
- 21.22
- Period
- 2018
- Total Assets
- 530.34
- Total Liabilities
- 115.57
- Total Equity
- 414.77
- Tangible Book Valueper Share Common Eq
- 63.7
- Period
- 2018
- Cashfrom Operating Activities
- 103.15
- Cashfrom Investing Activities
- 1.88
- Cashfrom Financing Activities
- -87.3
- Net Changein Cash
- 17.96
- Period
- 2024-12-31
- Total Revenue
- 322.77
- Selling/ General/ Admin Expenses Total
- 81.43
- Depreciation/ Amortization
- 27.7
- Other Operating Expenses Total
- 102.38
- Total Operating Expense
- 278.45
- Operating Income
- 44.31
- Net Income Before Taxes
- 42.34
- Net Income
- 31.36
- Diluted Normalized EPS
- 6.09
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 349.79
- Selling/ General/ Admin Expenses Total
- 78.44
- Depreciation/ Amortization
- 26.82
- Other Operating Expenses Total
- 108.94
- Total Operating Expense
- 286.73
- Operating Income
- 63.06
- Net Income Before Taxes
- 61.4
- Net Income
- 46.52
- Diluted Normalized EPS
- 9.03
- Period
- 2024-09-30
- Total Assets
- 1631.23
- Total Liabilities
- 447.29
- Total Equity
- 1183.94
- Tangible Book Valueper Share Common Eq
- 67.72
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 122.47
- Cashfrom Investing Activities
- -98.62
- Cashfrom Financing Activities
- -41.91
- Net Changein Cash
- -18.23
- Period
- 2024-06-30
- Total Revenue
- 313.36
- Selling/ General/ Admin Expenses Total
- 71.69
- Depreciation/ Amortization
- 25.54
- Other Operating Expenses Total
- 97.04
- Total Operating Expense
- 260.08
- Operating Income
- 53.27
- Net Income Before Taxes
- 51.08
- Net Income
- 37.95
- Diluted Normalized EPS
- 7.37
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 331
- Selling/ General/ Admin Expenses Total
- 71.47
- Depreciation/ Amortization
- 26.42
- Other Operating Expenses Total
- 106.2
- Total Operating Expense
- 277.44
- Operating Income
- 53.56
- Net Income Before Taxes
- 50.53
- Net Income
- 36.41
- Diluted Normalized EPS
- 7.09
- Period
- 2024-03-31
- Total Assets
- 1555.06
- Total Liabilities
- 458.91
- Total Equity
- 1096.16
- Tangible Book Valueper Share Common Eq
- 49.8
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 263.56
- Cashfrom Investing Activities
- -89.41
- Cashfrom Financing Activities
- -181.2
- Net Changein Cash
- -6.22
- Period
- 2023-12-31
- Total Revenue
- 291.12
- Selling/ General/ Admin Expenses Total
- 69.51
- Depreciation/ Amortization
- 24.99
- Other Operating Expenses Total
- 97.42
- Total Operating Expense
- 251.26
- Operating Income
- 39.86
- Net Income Before Taxes
- 36.85
- Net Income
- 27.16
- Diluted Normalized EPS
- 5.28
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 308.5
- Selling/ General/ Admin Expenses Total
- 69.75
- Depreciation/ Amortization
- 22.24
- Other Operating Expenses Total
- 99.86
- Total Operating Expense
- 255.93
- Operating Income
- 52.57
- Net Income Before Taxes
- 48.11
- Net Income
- 35.45
- Diluted Normalized EPS
- 6.9
- Period
- 2023-09-30
- Total Assets
- 1509.14
- Total Liabilities
- 462.64
- Total Equity
- 1046.5
- Tangible Book Valueper Share Common Eq
- 41.95
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 108.59
- Cashfrom Investing Activities
- -48.06
- Cashfrom Financing Activities
- -73.55
- Net Changein Cash
- -17.9
- Period
- 2023-06-30
- Total Revenue
- 277.09
- Selling/ General/ Admin Expenses Total
- 65.06
- Depreciation/ Amortization
- 20.82
- Other Operating Expenses Total
- 89.71
- Total Operating Expense
- 234.97
- Operating Income
- 42.12
- Net Income Before Taxes
- 39.19
- Net Income
- 28.8
- Diluted Normalized EPS
- 5.62
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 282.55
- Selling/ General/ Admin Expenses Total
- 64.31
- Depreciation/ Amortization
- 23.43
- Other Operating Expenses Total
- 88.1
- Total Operating Expense
- 235.69
- Operating Income
- 46.85
- Net Income Before Taxes
- 41.9
- Net Income
- 33.36
- Diluted Normalized EPS
- 6.5
- Period
- 2023-03-31
- Total Assets
- 1501.61
- Total Liabilities
- 513.38
- Total Equity
- 988.23
- Tangible Book Valueper Share Common Eq
- 30.99
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 247.09
- Cashfrom Investing Activities
- 46.79
- Cashfrom Financing Activities
- -292.33
- Net Changein Cash
- 2.85
- Period
- 2022-12-31
- Total Revenue
- 285.46
- Selling/ General/ Admin Expenses Total
- 64.57
- Depreciation/ Amortization
- 23.03
- Other Operating Expenses Total
- 84.61
- Total Operating Expense
- 238
- Operating Income
- 47.46
- Net Income Before Taxes
- 47.97
- Net Income
- 35.8
- Diluted Normalized EPS
- 6.97
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Metropolis Healthcare Technical
Moving Average
SMA
- 5 Day1744.77
- 10 Day1688.15
- 20 Day1629.77
- 50 Day1671.58
- 100 Day1852.62
- 300 Day1982.53
Metropolis Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Rainbow Childrens Medicare
- 1374
- 16.3
- 1.2
- 1708.5
- 1079.25
- 14021.53
- Vijaya Diagnostic Centre
- 1001.8
- -14.55
- -1.43
- 1276.75
- 654.75
- 10291.02
- Metropolis Healthcare
- 1705.9
- -0.15
- -0.01
- 2306.85
- 1383.7
- 8766.06
- Healthcare Global Enterprises
- 567.75
- 21.55
- 3.95
- 606.15
- 310.1
- 7903.28
- Kovai Medical Cente And Hospital
- 5560.5
- -24.45
- -0.44
- 6400
- 3750
- 6079.66
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Rainbow Childrens Medicare
- 64.9
- 11.15
- 19.88
- 13.8
- Vijaya Diagnostic Centre
- 89.52
- 16.17
- 22.14
- 21.2
- Metropolis Healthcare
- 70.32
- 8.17
- 20.59
- 14.66
- Healthcare Global Enterprises
- 170.5
- 9.38
- -4.88
- -3.5
- Kovai Medical Cente And Hospital
- 33.47
- 6.78
- 19.28
- 12.23
Metropolis Healthcare Shareholding
Shareholding Pattern
*Promoter pledging: 0.58%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 04-Feb-25
- Quarterly Results
- 09-Dec-24
- Preferential issue of shares
- 08-Nov-24
- Quarterly Results
- 10-Aug-24
- Quarterly Results
- 21-May-24
- Audited Results
- 02-Feb-24
- Quarterly Results
- 04-Nov-23
- Quarterly Results & Interim Dividend
- 02-Aug-23
- Quarterly Results
- 16-May-23
- Audited Results
- 10-Feb-23
- Quarterly Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 11-Feb-25
- 10-Jan-25
- POM
- 21-Aug-24
- 31-Jul-24
- AGM
- 30-Oct-23
- 28-Sept-23
- POM
- 17-Aug-23
- 24-Jul-23
- AGM
- 11-Aug-21
- 05-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 06-Nov-23
- 17-Nov-23
- 17-Nov-23
- 4
- 07-Feb-23
- 23-Feb-23
- 23-Feb-23
- 8
- 03-Feb-22
- 22-Feb-22
- 21-Feb-22
- 8
- 04-Feb-21
- 19-Feb-21
- 17-Feb-21
- 8


